Overall Group 1 Group 2 P value
Survival 1-year 5-years 10-years 15-years 85.4% (2.7) 65.1% (3.7) 43.7% (4.2) 16.7% (4.5) 86.7% (3.6) 63.8% (5.1) 32.8% (5.5) 12.4% (6.0) 84.1% (3.9) 66.4% (5.2) 56.8% (5.8) 21.4% (6.52) 0.575 0.880 0.062 0.206
Complications* No complications P value
Survival 1-year 5-years 10-years 15-years 90% (6.7) 54% (11.4) 42% (11.6) 0 93% (2.1) 73% (3.8) 48% (11.6) 23% (5.8) 0.623 0.069 0.356 0.023
Injury at re-entry# No injury at re-entry P value
Survival 1-year 5-years 10-years 15-years 68% (9.9) 46% (10.6) 40% (10.7) 20% (11.3) 88% (2.7) 67% (3.9) 43% (4.6) 16% (5.1) 0.011 0.025 0.149 0.264
*Postoperative TIA/stroke, renal failure requiring new hemofiltration, deep sternal wound infection, re-exploration for bleeding/tamponade and length of stay >30 days # involving LIMA, vein graft(s), right atrium, right ventricle, aorta, pulmonary artery *Postoperative TIA/stroke, renal failure requiring new hemofiltration, deep sternal wound infection, re-exploration for bleeding/tamponade and length of stay >30 days # involving LIMA, vein graft(s), right atrium, right ventricle, aorta, pulmonary artery *Postoperative TIA/stroke, renal failure requiring new hemofiltration, deep sternal wound infection, re-exploration for bleeding/tamponade and length of stay >30 days # involving LIMA, vein graft(s), right atrium, right ventricle, aorta, pulmonary artery *Postoperative TIA/stroke, renal failure requiring new hemofiltration, deep sternal wound infection, re-exploration for bleeding/tamponade and length of stay >30 days # involving LIMA, vein graft(s), right atrium, right ventricle, aorta, pulmonary artery *Postoperative TIA/stroke, renal failure requiring new hemofiltration, deep sternal wound infection, re-exploration for bleeding/tamponade and length of stay >30 days # involving LIMA, vein graft(s), right atrium, right ventricle, aorta, pulmonary artery